PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34418561-6	2021	Among ALK/ROS1 inhibitors, crizotinib had highest odds of conduction disease (ROR 1.75, 99% CI: 1.30-2.36) and QT prolongation (ROR 1.91, 99% CI: 1.22-3.00).	Crizotinib	27-37	receptor tyrosine kinase like orphan receptor 1	Homo sapiens	78-83	
34418561-6	2021	Among ALK/ROS1 inhibitors, crizotinib had highest odds of conduction disease (ROR 1.75, 99% CI: 1.30-2.36) and QT prolongation (ROR 1.91, 99% CI: 1.22-3.00).	Crizotinib	27-37	receptor tyrosine kinase like orphan receptor 1	Homo sapiens	128-133